Amsurg Corp. (AMSG) Position Decreased by First Trust Advisors LP
First Trust Advisors LP cut its stake in shares of Amsurg Corp. (NASDAQ:AMSG) by 52.8% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 31,633 shares of the company’s stock after selling 35,413 shares during the period. First Trust Advisors LP owned 0.06% of Amsurg Corp. worth $2,453,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. State Street Corp boosted its position in shares of Amsurg Corp. by 3.9% in the first quarter. State Street Corp now owns 1,821,003 shares of the company’s stock worth $135,849,000 after buying an additional 68,181 shares in the last quarter. Wellington Management Group LLP boosted its position in shares of Amsurg Corp. by 3.8% in the first quarter. Wellington Management Group LLP now owns 995,109 shares of the company’s stock worth $74,235,000 after buying an additional 36,155 shares in the last quarter. Royal Bank of Canada boosted its position in shares of Amsurg Corp. by 1.9% in the first quarter. Royal Bank of Canada now owns 507,205 shares of the company’s stock worth $37,839,000 after buying an additional 9,438 shares in the last quarter. Barclays PLC boosted its position in shares of Amsurg Corp. by 1,114.2% in the first quarter. Barclays PLC now owns 8,803 shares of the company’s stock worth $652,000 after buying an additional 8,078 shares in the last quarter. Finally, BlackRock Group LTD boosted its position in shares of Amsurg Corp. by 24.4% in the first quarter. BlackRock Group LTD now owns 38,307 shares of the company’s stock worth $2,858,000 after buying an additional 7,509 shares in the last quarter. 98.42% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Amsurg Corp. (NASDAQ:AMSG) traded up 1.62% during midday trading on Wednesday, hitting $63.87. The stock had a trading volume of 1,268,970 shares. Amsurg Corp. has a 52-week low of $58.37 and a 52-week high of $87.42. The company’s 50 day moving average is $66.32 and its 200 day moving average is $73.88. The company has a market cap of $3.43 billion, a PE ratio of 18.95 and a beta of 0.65.
Amsurg Corp. (NASDAQ:AMSG) last posted its quarterly earnings data on Tuesday, August 2nd. The company reported $1.10 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.08 by $0.02. Amsurg Corp. had a return on equity of 8.20% and a net margin of 6.53%. The company had revenue of $758.50 million for the quarter, compared to analysts’ expectations of $769.88 million. During the same period in the previous year, the firm posted $0.97 EPS. Amsurg Corp.’s revenue was up 21.5% compared to the same quarter last year. On average, analysts anticipate that Amsurg Corp. will post $4.33 earnings per share for the current year.
AMSG has been the topic of a number of research reports. Bank of America Corp. raised Amsurg Corp. from a “neutral” rating to a “buy” rating and set a $104.00 price objective on the stock in a report on Thursday, June 16th. Jefferies Group reissued a “buy” rating on shares of Amsurg Corp. in a report on Sunday, July 3rd. Citigroup Inc. cut Amsurg Corp. from a “buy” rating to a “neutral” rating in a report on Thursday, June 16th. Wells Fargo & Co. assumed coverage on Amsurg Corp. in a report on Tuesday, June 14th. They set a “market perform” rating on the stock. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $95.00 price target on shares of Amsurg Corp. in a research note on Thursday, July 14th. Four analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $93.90.
In related news, insider Robert Jon Coward sold 7,500 shares of Amsurg Corp. stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $63.65, for a total value of $477,375.00. Following the sale, the insider now directly owns 97,507 shares in the company, valued at approximately $6,206,320.55. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 2.30% of the stock is owned by corporate insiders.
About Amsurg Corp.
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Want to see what other hedge funds are holding AMSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amsurg Corp. (NASDAQ:AMSG).
Receive News & Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.